← All diseases
Cancer
Lung cancer (non-small cell)
Do you want to receive a message when there is new research on Lung cancer (non-small cell)? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, one sentence appears above each publication explaining what was studied — and you'll be notified as soon as new research about Lung cancer (non-small cell) is available. View what Premium costs.
Publications and studies (3193)
- Prognostic value of perioperative inflammatory biomarkers in patients undergoing surgical resection for non-small cell lung cancer. (2026/06/30) ♡
- A plasma proteomic signature of cancer-related sarcopenia implicates the IGFBP axis in muscle dysfunction. (2026/06/29) ♡
- Deziyangxin suppresses non-small cell lung cancer through remodeling of the tumor immune microenvironment. (2026/06/28) ♡
- Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. Heat-sensitive Moxibustion Enhances Immunity in Advanced Non-small Cell Lung Cancer via Th1/Th2 and Treg/Th17 Regulation. (2026/06/28) ♡
- Identification of unannotated microproteins involved in endothelial cell homeostasis, dysfunction, and vascular disease. (2026/06/26) ♡
- Body mass index and fasting insulin predict survival and EGFR-TKI benefit in Stage IV lung adenocarcinoma. (2026/06/25) ♡
- Prehabilitation in lung cancer patients undergoing lung resection surgery (Fit4LungNeo): study protocol. (2026/06/19) ♡
- Integrative Analysis of Glycosylation-Related Genes Reveals Prognostic Subtypes, Immune Evasion, and Therapeutic Vulnerabilities in Lung Adenocarcinoma. (2026/06/16) ♡
- Effect of hypoalbuminemia on postoperative pulmonary complications after thoracoscopic anatomical lung resection: a retrospective cohort study. (2026/06/11) ♡
- Variability of the prognostic nutritional index within 3 months after curative resection for non-small cell lung cancer and 2-year recurrence-free survival. (2026/06/06) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Real-World 30-Day Mortality After the Last Dose of Immune Checkpoint Inhibitors: A Multicenter Retrospective Cohort Study in Turkey. (2026/06/06) ♡
- Cost-Effectiveness Analysis of Anamorelin and Olanzapine for Cancer Cachexia in Non-Small Cell Lung Cancer Patients in Japan. (2026/06/04) ♡
- Comparison of PNI and GNRI nomogram models for predicting postoperative complications in elderly patients with lung cancer: a retrospective study. (2026/06/04) ♡
- Associations between early loss of skeletal muscle and osimertinib trough concentrations in patients with advanced EGFR-mutated NSCLC. (2026/06/03) ♡
- Zi Shen decoction inhibits non-small cell lung cancer progression by regulating macrophage polarization via the gut microbiota. (2026/06/02) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Submucosal-Predominant (Inverted-Type) Pyloric Gland Adenoma of the Duodenum Mimicking Malignancy. (2026/06/02) ♡
- Assessment of Circulating Cell Free DNA Methylation Biomarker of Panel of Selected Genes for Lung Cancer Detection. (2026/06/01) ♡
- Circular RNA ribosomal protein L15 accelerates epithelial mesenchymal transformation and tumour growth in non-small cell lung carcinoma via modulating the microRNA-518c-3p/WD repeat protein 1 axis. (2026/06/01) ♡
- Traditional Chinese medicine for non-small cell lung carcinoma: An evidence mapping. (2026/06/01) ♡
- Yifei Sanjie pill combined with gefitinib reduces the progression of EGFR-TKIs-resistant non-small cell lung cancer via YAP/ANKRD1 axis. (2026/06/01) ♡
- Sijunzi Decoction Reverses Metabolic Adaptation and Induces Ferroptosis in Cisplatin-Resistant Non-small Cell Lung Cancer: An Integrative Metabolomics-Pharmacology Analysis. (2026/06/01) ♡
- Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Evaluating eight smoking metrics for modelling survival in non-small cell lung cancer. (2026/06/01) ♡
- Clinical Factors Associated With Non-Completion of Durvalumab Maintenance Therapy After Chemoradiotherapy in Patients With Locally Advanced Non-Small Cell Lung Cancer: A Single-Center Retrospective Study. (2026/06/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Perioperative Considerations of Neoadjuvant and Perioperative Chemoimmunotherapy for Resectable Lung Cancer. (2026/05/29) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. [Above and beyond BMI: Deciphering the lung cancer paradox]. (2026/05/21) ♡
- Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Association between the prognostic nutritional index and prognosis in patients with non-small cell lung cancer undergoing curative lung resection: a systematic review and meta-analysis. (2026/05/21) ♡
- Prognostic value of emotional distress in advanced non-small cell lung cancer: a systematic review and meta-analysis. (2026/05/20) ♡
- Comparative Treatment Outcomes Across Actionable Genomic Alterations in NSCLC: A Large Multicenter Real-World Study. (2026/05/20) ♡
- Huayu Wan enhances immune checkpoint inhibitor efficacy in triple-negative breast cancer by normalizing tumor vasculature and remodeling the tumor immune microenvironment. (2026/05/19) ♡
- Glutamine Starvation Induces Ferroptosis in NSCLC via AMPK/PDZD8-Mediated Ferritinophagy. (2026/05/18) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Pathogenesis and novel therapeutic perspectives in non-small cell lung cancer: Focusing on PI3K/AKT pathway regulation by traditional Chinese medicine monomers. (2026/05/15) ♡
- Exploring the prognostic value of the magnesium-immune prognostic score (MIPS) in metastatic non-small cell lung cancer receiving Nivolumab. (2026/05/01) ♡
- Particulate matter exposure negatively affects the cancer immunosurveillance through PD-L1 upregulation and dendritic cell maturation suppression. (2026/05/01) ♡
- Use of an Integrative Genomics Approach to Identify Metastatic NSCLC Patients Benefiting From the Addition of Chemotherapy to Immune Checkpoint Inhibitors. (2026/05/01) ♡
- Isoliquiritigenin combined with gemcitabine inhibited lung cancer by suppressing JAK2/STAT3 signaling via lncRNA-p21/miRNA-4534 axis. (2026/05/01) ♡
- Synergistic effects through targeting the PI3K and IGFR pathways in treating lung cancer carrying activation alterations along the PI3K pathway. (2026/05/01) ♡
- Pneumonitis risk from pembrolizumab in non-small cell lung cancer: Interstitial abnormalities matter, and so does treatment. (2026/05/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. [Metabolic and cardiovascular disorders with lorlatinib: How to detect and manage them in practice?]. (2026/05/01) ♡
- Brief Report: A Pilot Study Evaluating the Feasibility, Safety, and Compliance With a Fasting-Mimicking Diet in Patients With Metastatic Non-Small Cell Lung Cancer. (2026/05/01) ♡
- Oncologic outcomes after declining lung cancer surgery: mixed methods analysis of a prospective pilot cohort. (2026/04/30) ♡
- Association between planetary health diet index and lung cancer risk in 106,542 participants: a prospective cohort study. (2026/04/29) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The Interplay of Preoperative Sarcopenia, Systemic Inflammation, and Neoadjuvant Therapy in Resectable NSCLC-Identifying the Gap: A Narrative Review of Surgical and Oncological Outcomes. (2026/04/29) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Will We Need a Novel Heuristic in Resectable Lung Cancer?: A Narrative Review. (2026/04/25) ♡
- Prognostic value of CALLY index in patients with locally advanced non-small cell lung cancer treated with thoracic radiotherapy. (2026/04/24) ♡
- Efficacy and Safety of Acupuncture for Pain in Non-Small Cell Lung Cancer: A Meta-Analysis. (2026/04/21) ♡
- Prognostic value of the Scottish Inflammatory Prognostic Score in advanced NSCLC treated with second-line nivolumab. (2026/04/21) ♡
- Prognostic value of chemotherapy-related mean corpuscular hemoglobin (MCH) kinetics in patients with non-small cell lung cancer receiving adjuvant chemotherapy. (2026/04/21) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Impact of Nutritional Status and Body Composition on Osimertinib Tolerance in Non-Small-Cell Lung Cancer. (2026/04/20) ♡
- A real-world study on the comparative effectiveness of first-line treatment regimens in advanced NSCLC patients with PACC mutations. (2026/04/20) ♡
- Baseline vitamin D status and clinical outcomes in advanced non-small cell lung cancer patients treated with nivolumab. (2026/04/14) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.